Lincomycin  -  Lincosamide antibiotic

  
Manufacturers of  Lincomycin Injection - Lincosamide antibiotic drug

  

 Action :

Effective against most Gram-postive organisms. Bacteriostatic or bactericidal depending on sensitivity and concentration. Susceptible organisms Bacteriostatic bactericidal depending on sensitivity and concentration. Susceptible organisms include Staph. Aureus. Staph albus, beta-haemolytic Streptococcus, Strep. viridans, Diplococcus pneumoniae, Clostridum tetani, C. perfringens, Corynebacterium diphtheriae and C. acnes. Not active against Strep. faecalis, Neisseriae, Haemophilus or other Gram-negative pathogens.

  

 Indication :

URI, LRTI, skin infections, septicaemia caused by Staph aureus & streptococcus, bone & joint infection including acute haematogenous osteomyelitis.

    

 Contraindication :

Hypersensitivity.

  

 Adverse-Effects :

Same as clindamycin.

  

 Special Precaution :

During prolonged therapy perform liver and kidney function tests, blood counts.

  

 Interactions :

Neuromuscular blocking agents : Use with cautions since actions of these agents are enhanced.

  

 Dosage :

Adults : Oral : 500mg 3-4 times daily.

  

 Duration of action :

Half-life is about 8 hours. 

    

 Strength & Packing :

 

  
*  for the use of a registered Medical practitioner or a Hospital or a Laboratory only.

  

  

Export Product List


[Go Back to the Export product list]

   
  

   

  

  

Disclaimer : This guide is provided for information purposes only, and for use of a registered medical practitioner or a hospital or a laboratory only. The authors, webmaster, or respective references / links are no way responsible for the content of the information. Although a concerted effort has been made to ensure the validity of the information contained in this document, we give no assurance for the accuracy of the information in this documents.